patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
MO_1012	PIK3CA p.E545A (Missense)	PIK3CA	Pictilisib	290	1533	162	604	3.216	7.274	12.138	4.1	15.02	75.056	0.019	54787.0
MO_1012	PIK3CA p.E545A (Missense)	PIK3CA Somatic Variant	Pictilisib	161	1662	103	663	2.898	5.162	7.855	4.104	14.658	71.812	0.0	41486.5
MO_1012	PIK3CA p.E545A (Missense)	PIK3CA Somatic Variant Missense	Pictilisib	153	1670	98	668	2.907	5.109	7.933	4.1	14.595	71.548	0.001	39841.5
MO_1012	PIK3CA p.E545A (Missense)	PIK3CA Somatic Variant Missense p.E545A	Pictilisib	2	1821	1	765	0.801	0.801		3.8	13.398	66.986	0.143	706.5
MO_1012	FIP1L1--THG1L Fusion	FIP1L1	Imatinib	81	1742	18	389	18.112	19.382	13.873	18.315	21.375	16.133	0.689	3696.5
MO_1012	FIP1L1--THG1L Fusion	THG1L	Imatinib	61	1762	18	389	16.119	18.265	12.228	18.315	21.427	16.183	0.412	3901.5
MO_1012	FIP1L1--THG1L Fusion	FIP1L1 Fusions	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	FIP1L1--THG1L Fusion	THG1L Fusions	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	FIP1L1--THG1L Fusion	FIP1L1--THG1L	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	RFX6--BCR Fusion	RFX6	Bosutinib	151	1672	96	850	6.334	15.941	19.717	5.973	11.576	13.61	0.143	37078.0
MO_1012	RFX6--BCR Fusion	BCR	Bosutinib	170	1653	113	833	5.836	12.696	15.58	6.02	11.927	14.235	0.747	47944.5
MO_1012	RFX6--BCR Fusion	RFX6 Fusions	Bosutinib	0	1823	0	946				6.015	12.019	14.396	nan	
MO_1012	RFX6--BCR Fusion	BCR Fusions	Bosutinib	14	1809	14	932	0.655	4.379	10.382	6.154	12.134	14.421	3.046e-05	10756.0
MO_1012	RFX6--BCR Fusion	RFX6--BCR	Bosutinib	0	1823	0	946				6.015	12.019	14.396	nan	
MO_1012	MUTYH--FIP1L1 Fusion	MUTYH	Imatinib	72	1751	18	389	19.323	20.017	11.639	18.187	21.346	16.213	0.958	3475.0
MO_1012	MUTYH--FIP1L1 Fusion	FIP1L1	Imatinib	81	1742	18	389	18.112	19.382	13.873	18.315	21.375	16.133	0.689	3696.5
MO_1012	MUTYH--FIP1L1 Fusion	MUTYH Fusions	Imatinib	2	1821	0	407				18.312	21.287	16.03	nan	
MO_1012	MUTYH--FIP1L1 Fusion	FIP1L1 Fusions	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	MUTYH--FIP1L1 Fusion	MUTYH--FIP1L1	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	EMC1--ALK Fusion	EMC1	Alectinib	114	1709	71	846	52.433	60.435	42.182	49.092	53.673	38.933	0.224	27428.0
MO_1012	EMC1--ALK Fusion	ALK	Alectinib	182	1641	120	797	47.502	52.663	47.815	49.517	54.428	37.778	0.118	52054.0
MO_1012	EMC1--ALK Fusion	EMC1 Fusions	Alectinib	2	1821	2	915	66.501	66.501	34.105	49.283	54.17	39.234	0.495	659.0
MO_1012	EMC1--ALK Fusion	ALK Fusions	Alectinib	10	1813	10	907	0.065	10.464	20.831	49.555	54.679	39.101	1.647e-05	8124.0
MO_1012	EMC1--ALK Fusion	EMC1--ALK	Alectinib	0	1823	0	917				49.283	54.197	39.212	nan	
MO_1012	KIF13A--EML4 Fusion	KIF13A	Crizotinib	139	1684	87	650	22.274	62.174	123.359	26.918	55.102	98.995	0.386	29891.0
MO_1012	KIF13A--EML4 Fusion	EML4	Crizotinib	93	1730	54	683	14.709	48.576	68.848	26.084	56.519	104.294	0.198	20380.0
MO_1012	KIF13A--EML4 Fusion	KIF13A Fusions	Crizotinib	3	1820	3	734	54.455	49.898	43.094	25.4	55.962	102.285	0.669	943.0
MO_1012	KIF13A--EML4 Fusion	EML4 Fusions	Crizotinib	5	1818	3	734	1.5	34.609	58.287	25.482	56.024	102.256	0.253	1522.0
MO_1012	KIF13A--EML4 Fusion	KIF13A--EML4	Crizotinib	0	1823	0	737				25.427	55.937	102.102	nan	
MO_1012	CREBZF--COL1A1 Fusion	CREBZF	Imatinib	122	1701	27	380	18.113	25.405	24.736	18.314	20.994	15.231	0.769	4956.0
MO_1012	CREBZF--COL1A1 Fusion	COL1A1	Imatinib	130	1693	37	370	19.015	20.406	11.327	18.171	21.375	16.435	0.835	6702.0
MO_1012	CREBZF--COL1A1 Fusion	CREBZF Fusions	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	CREBZF--COL1A1 Fusion	COL1A1 Fusions	Imatinib	1	1822	0	407				18.312	21.287	16.03	nan	
MO_1012	CREBZF--COL1A1 Fusion	CREBZF--COL1A1	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	FOSL1--SLC45A3 Fusion	FOSL1	Sorafenib	63	1760	36	721	10.58	67.064	229.512	11.526	35.784	97.079	0.835	12710.5
MO_1012	FOSL1--SLC45A3 Fusion	SLC45A3	Sorafenib	76	1747	41	716	8.069	29.259	77.835	11.848	37.73	108.503	0.026	17713.5
MO_1012	FOSL1--SLC45A3 Fusion	FOSL1 Fusions	Sorafenib	0	1823	0	757				11.486	37.271	107.045	nan	
MO_1012	FOSL1--SLC45A3 Fusion	SLC45A3 Fusions	Sorafenib	1	1822	1	756	467.394	467.394		11.473	36.702	105.964	0.089	6.0
MO_1012	FOSL1--SLC45A3 Fusion	FOSL1--SLC45A3	Sorafenib	0	1823	0	757				11.486	37.271	107.045	nan	
MO_1012	FLT3 p.R311W (Missense)	FLT3	Sunitinib	190	1633	52	346	15.1	46.352	71.421	10.402	33.152	60.495	0.319	8225.0
MO_1012	FLT3 p.R311W (Missense)	FLT3 Somatic Variant	Sunitinib	78	1745	25	373	6.801	41.337	83.169	10.855	34.444	60.541	0.187	5398.0
MO_1012	FLT3 p.R311W (Missense)	FLT3 Somatic Variant Missense	Sunitinib	68	1755	20	378	4.73	33.386	83.789	11.104	34.956	60.877	0.031	4864.0
MO_1012	FLT3 p.R311W (Missense)	FLT3 Somatic Variant Missense p.R311W	Sunitinib	2	1821	0	398				10.692	34.877	62.092	nan	
MO_1012	PDGFRA--NTF4 Fusion	PDGFRA	Imatinib	131	1692	31	376	22.608	25.29	24.218	18.171	20.957	15.16	0.586	5484.5
MO_1012	PDGFRA--NTF4 Fusion	NTF4	Imatinib	56	1767	17	390	18.002	21.859	15.19	18.356	21.262	16.083	0.932	3274.0
MO_1012	PDGFRA--NTF4 Fusion	PDGFRA Fusions	Imatinib	1	1822	1	406	0.231	0.231		18.314	21.339	16.015	0.096	399.0
MO_1012	PDGFRA--NTF4 Fusion	NTF4 Fusions	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	PDGFRA--NTF4 Fusion	PDGFRA--NTF4	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	HIC2--PDGFRB Fusion	HIC2	Imatinib	141	1682	37	370	18.113	19.088	10.518	18.314	21.507	16.474	0.705	7104.0
MO_1012	HIC2--PDGFRB Fusion	PDGFRB	Imatinib	97	1726	25	382	14.738	17.634	11.397	18.456	21.526	16.27	0.126	5647.0
MO_1012	HIC2--PDGFRB Fusion	HIC2 Fusions	Imatinib	2	1821	0	407				18.312	21.287	16.03	nan	
MO_1012	HIC2--PDGFRB Fusion	PDGFRB Fusions	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	HIC2--PDGFRB Fusion	HIC2--PDGFRB	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MO_1012	BRCA2 p.A392V (Missense)	BRCA2	Olaparib	278	1545	164	598	86.83	180.683	296.561	71.302	159.004	329.462	0.071	44530.0
MO_1012	BRCA2 p.A392V (Missense)	BRCA2 Somatic Variant	Olaparib	180	1643	109	653	84.839	151.369	206.671	73.232	165.723	338.178	0.564	34362.0
MO_1012	BRCA2 p.A392V (Missense)	BRCA2 Somatic Variant Missense	Olaparib	133	1690	80	682	84.942	143.715	169.346	73.428	166.01	336.031	0.489	25990.0
MO_1012	BRCA2 p.A392V (Missense)	BRCA2 Somatic Variant Missense p.A392V	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MO_1012	RAD51D p.R266C (Missense)	RAD51D	Olaparib	67	1756	39	723	94.17	270.004	470.102	73.624	157.934	312.117	0.166	12242.5
MO_1012	RAD51D p.R266C (Missense)	RAD51D Somatic Variant	Olaparib	22	1801	11	751	83.193	113.91	143.685	75.276	164.398	324.476	0.653	4457.0
MO_1012	RAD51D p.R266C (Missense)	RAD51D Somatic Variant Missense	Olaparib	21	1802	10	752	77.604	116.982	151.076	75.933	164.29	324.274	0.612	4111.0
MO_1012	RAD51D p.R266C (Missense)	RAD51D Somatic Variant Missense p.R266C	Olaparib	0	1823	0	762				75.933	163.67	322.6	nan	
MO_1012	DMBT1--BRD4 Fusion	DMBT1	JQ1	368	1455	12	36	22.123	29.847	30.382	19.854	80.106	265.173	0.991	215.0
MO_1012	DMBT1--BRD4 Fusion	BRD4	JQ1	140	1683	9	39	20.534	21.309	16.924	22.171	78.21	254.848	0.526	200.0
MO_1012	DMBT1--BRD4 Fusion	DMBT1 Fusions	JQ1	0	1823	0	48				21.304	67.541	230.354	nan	
MO_1012	DMBT1--BRD4 Fusion	BRD4 Fusions	JQ1	3	1820	0	48				21.304	67.541	230.354	nan	
MO_1012	DMBT1--BRD4 Fusion	DMBT1--BRD4	JQ1	0	1823	0	48				21.304	67.541	230.354	nan	
MO_1012	MIR145--ERG Fusion	MIR145	Rucaparib	31	1792	19	921	39.195	48.252	35.882	34.998	46.168	42.955	0.514	7984.0
MO_1012	MIR145--ERG Fusion	ERG	Rucaparib	114	1709	72	868	30.195	37.386	30.442	35.672	46.942	43.61	0.167	34310.0
MO_1012	MIR145--ERG Fusion	MIR145 Fusions	Rucaparib	0	1823	0	940				35.036	46.21	42.808	nan	
MO_1012	MIR145--ERG Fusion	ERG Fusions	Rucaparib	7	1816	6	934	42.35	38.998	23.018	35.036	46.257	42.909	0.99	2793.0
MO_1012	MIR145--ERG Fusion	MIR145--ERG	Rucaparib	0	1823	0	940				35.036	46.21	42.808	nan	
MO_1012	CCND3--CDKN1A Fusion	CCND3	Palbociclib	74	1749	44	726	16.738	115.815	410.428	40.565	108.537	243.223	0.005	20039.5
MO_1012	CCND3--CDKN1A Fusion	CDKN1A	Palbociclib	59	1764	33	737	43.461	77.737	98.987	38.414	110.35	260.089	0.737	11741.0
MO_1012	CCND3--CDKN1A Fusion	CCND3 Fusions	Palbociclib	0	1823	0	770				38.772	108.953	255.332	nan	
MO_1012	CCND3--CDKN1A Fusion	CDKN1A Fusions	Palbociclib	0	1823	0	770				38.772	108.953	255.332	nan	
MO_1012	CCND3--CDKN1A Fusion	CCND3--CDKN1A	Palbociclib	0	1823	0	770				38.772	108.953	255.332	nan	
MO_1012	CCND1--PPP1R13L Fusion	CCND1	Palbociclib	149	1674	85	685	49.442	103.934	113.526	37.669	109.575	267.787	0.032	24961.5
MO_1012	CCND1--PPP1R13L Fusion	PPP1R13L	Palbociclib	147	1676	70	700	42.593	87.342	114.968	38.534	111.114	265.268	0.959	24591.0
MO_1012	CCND1--PPP1R13L Fusion	CCND1 Fusions	Palbociclib	1	1822	0	770				38.772	108.953	255.332	nan	
MO_1012	CCND1--PPP1R13L Fusion	PPP1R13L Fusions	Palbociclib	3	1820	3	767	43.461	33.727	27.723	38.653	109.247	255.785	0.514	1402.0
MO_1012	CCND1--PPP1R13L Fusion	CCND1--PPP1R13L	Palbociclib	0	1823	0	770				38.772	108.953	255.332	nan	
MO_1012	CCND1--MYLK Fusion	CCND1	Palbociclib	149	1674	85	685	49.442	103.934	113.526	37.669	109.575	267.787	0.032	24961.5
MO_1012	CCND1--MYLK Fusion	MYLK	Palbociclib	149	1674	82	688	34.621	93.194	133.38	39.245	110.831	266.168	0.794	28704.5
MO_1012	CCND1--MYLK Fusion	CCND1 Fusions	Palbociclib	1	1822	0	770				38.772	108.953	255.332	nan	
MO_1012	CCND1--MYLK Fusion	MYLK Fusions	Palbociclib	1	1822	1	769	30.53	30.53		38.892	109.055	255.483	0.864	423.0
MO_1012	CCND1--MYLK Fusion	CCND1--MYLK	Palbociclib	0	1823	0	770				38.772	108.953	255.332	nan	
